Quanterix (QTRX) Return on Capital Employed (2018 - 2026)
Quanterix's (QTRX) quarterly Return on Capital Employed came in at 41.0% in Q1 2026, down 2332.0% YoY from 1.84% in Q1 2025, and down 16.48% on a QoQ basis from 35.2% in Q4 2025.
Quanterix (QTRX) Return on Capital Employed (2018 - 2026) Analysis & Trends
Quanterix (QTRX) has 9 years of Return on Capital Employed data on file, last reported at 41.0% in Q1 2026.
- Quarterly Return on Capital Employed fell 2332.0% year-over-year to 41.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 41.0% (down 2332.0% YoY) and the FY2025 annual result came in at 37.15%, down 2314.0% from the prior year.
- Return on Capital Employed slipped to 41.0% in Q1 2026, from 35.2% in the prior quarter.
- In the past five years, Return on Capital Employed ranged from a high of 11.8% in Q4 2023 to a low of 41.0% in Q1 2026.
- A 5-year average of 21.11% and a median of 17.67% in 2025 frame the typical range for Return on Capital Employed.
- Annual changes were most pronounced in 2023 — Return on Capital Employed surged 1375 bps — and 2026, when it slumped 2332 bps.
- Tracing QTRX's Return on Capital Employed over 5 years: stood at 25.54% in 2022, then jumped by 54 bps to 11.8% in 2023, then decreased by 22 bps to 14.35% in 2024, then sank by 145 bps to 35.2% in 2025, then slipped by 16 bps to 41.0% in 2026.
- The last three Return on Capital Employed figures came in at 41.0% (Q1 2026), 35.2% (Q4 2025), and 34.75% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn | 12.08% |
| 10 | Quanterix | 141.97 Mn | 48.44 Mn | 12.67 Mn | -52.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -52.21% |
| Mar 31, 2026 | -41.00% |
| Dec 31, 2025 | -35.20% |
| Sep 30, 2025 | -34.75% |
| Jun 30, 2025 | -26.63% |
| Mar 31, 2025 | -17.67% |
| Dec 31, 2024 | -14.35% |
| Sep 30, 2024 | -13.65% |
| Jun 30, 2024 | -13.94% |
| Mar 31, 2024 | -13.01% |
| Dec 31, 2023 | -11.80% |
| Sep 30, 2023 | -13.69% |
| Jun 30, 2023 | -20.01% |
| Mar 31, 2023 | -24.09% |
| Dec 31, 2022 | -25.54% |
| Sep 30, 2022 | -22.98% |
| Jun 30, 2022 | -16.92% |
| Mar 31, 2022 | -13.69% |
| Dec 31, 2021 | -12.05% |
| Sep 30, 2021 | -9.96% |